[{"Assets_0_Q3_USD":3897922000.0,"EarningsPerShareBasic_1_Q3_USD":5.93,"EarningsPerShareBasic_3_Q3_USD":7.14,"EarningsPerShareDiluted_1_Q3_USD":5.88,"EarningsPerShareDiluted_3_Q3_USD":7.08,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":155672000.0,"NetIncomeLoss_1_Q3_USD":314793000.0,"NetIncomeLoss_3_Q3_USD":379257000.0,"StockholdersEquity_0_Q3_USD":1217437000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":53543000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":53531000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":53129000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":53089000.0,"Ticker":"PBH","CIK":"1295947","name":"PRESTIGE BRANDS HOLDINGS, INC.","OfficialName":"Prestige Consumer Healthcare Inc. Common Stock","form":"10-Q","period":"20171231","fy":"2017.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"2689675976.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"nan","filed":"20180201"}]